HK shares of WuXi Bio, WuXi AppTec jump on report cos explore sale of pharma operations

WuXi Biologics (Cayman)

04/10/2024 03:20

** Hong Kong-listed shares of WuXi Biologics  2269.HK  jump
8.3% to HK$20.30, and are third-biggest pct gainers in the
benchmark Hang Seng Index  .HSI  
    ** WuXi Biologics and WuXi AppTec  603259.SS  are planning
to sell some of their operations after the Chinese biotech
companies were targeted by the U.S. on national security
grounds, the Financial Times reported on Thursday
    ** WuXi Biologics and WuXi AppTec did not immediately
respond to Reuters' requests for a comment
    ** The U.S. House of Representatives passed a bill last
month aiming to restrict business with China's WuXi AppTec and
several other biotech companies on national security grounds
    ** Hong Kong stock of WuXi AppTec  2359.HK  jumps 7.3% to
HK$64.55, and is fourth-biggest pct gainer in Hang Seng Index
 .HSI , which is up 0.4%
    ** Hang Seng Commerce & Industry Index  .HSNC  gains 0.8%,
and healthcare index  .HSCIH  rises 1.7% 
    
    

 (Reporting by Donny Kwok)
 ((donny.kwok@thomsonreuters.com))